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Abstract The high-affinity E1ATP site of Na+/K+-ATPase
labeled with fluorescein 5P-isothiocyanate and its E2ATP site
labeled with erythrosin 5P-isothiocyanate (ErITC), as was shown
recently [Linnertz et al. (1998) J. Biol. Chem. 273, 28813^
28821], reside on separate and adjacent catalytic K subunits. This
paper provides evidence that specific labeling of the E2ATP
binding site with ErITC resulted in a modification of the Cys549
residue in the tryptic fragment with the sequence Val545-Leu-
Gly-Phe-Cys549-His550. Hence, Cys549 is part of or close to the
low-affinity E2ATP binding site of Na
+/K+-ATPase.
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1. Introduction
Na/K-ATPase is an integral membrane protein which
transports sodium and potassium ions against an electrochem-
ical gradient. The transport of Na and K is presumably
connected with the oscillation of the enzyme between two
major conformational states, designated E1Na and E2K.
The E1 and E2 states have di¡erent a⁄nities for ATP [1]. A
reaction mechanism assuming consecutive changes of a single
ATP site during the catalytic process, the so-called Albers-
Post model, is inconsistent with the recent kinetic demonstra-
tion of simultaneously existing and cooperating ATP sites [2].
Consistent therewith is the observation that speci¢c labeling
of the high-a⁄nity E1ATP [3] or the low-a⁄nity E2ATP sites
does not block labeling and partial activity of the other empty
site [4,5]. The recent demonstration of a ‘superphosphoryla-
tion’, i.e. that at least 2 mol of phosphate can be incorporated
into the catalytic K subunit per mol of ouabain binding sites
[6], is consistent with the observation of a phosphorylation
from inorganic phosphate (Pi) during Na-ATPase activity
[7] and with the possibility that Na/K-ATPase is phos-
phorylated from both ATP sites [8].
There are a large number of experiments favoring the idea
that the two ATP sites reside on di¡erent K subunits [9,10].
Recently information on the location of the E1ATP and
E2ATP sites was obtained by a⁄nity labeling of the E1ATP
site with the £uorescent pseudo-ATP analog £uorescein 5P-
isothiocyanate (FITC) and of the E2ATP site with the £uo-
rescent pseudo-ATP analog erythrosin 5P-isothiocyanate
(ErITC) [11]. Foºrster energy transfer measurements gave in-
formation on the distance between the E2ATP site and the
E1ATP site. The distance of the low-a⁄nity ATP binding site
to the high-a⁄nity site was estimated to be R = 6.5 nm, too
large to localize both ATP binding sites on to the same cata-
lytic K subunit [11]. The amino acid sequence of the site bind-
ing ATP with low a⁄nity and reacting with ErITC in an
E1ATP-protected enzyme (by FITC) is not yet known but
amino acids contributing to the recognition and catalysis of
ATP at the high-a⁄nity E1ATP site have been de¢ned by
a⁄nity labeling of this site [12,13] with protein-reactive ATP
derivatives and the pseudo-ATP analog FITC [14,15]. Hence,
information on the amino acid sequence forming the low-af-
¢nity E2ATP binding site should be obtainable by a similar
procedure. Therefore, a⁄nity labeling of the low-a⁄nity
E2ATP site was done with ErITC in an enzyme whose E1ATP
site had been blocked by FITC. Subsequently, the amino acid
sequence was determined after isolation of the erythrosin-la-
beled tryptic peptide. This paper shows that ErITC labels
Cys549 within the cytosolic H4/H5 loop. This amino acid has
not been shown before to be a part of the ATP sites of Na/
K-ATPase.
2. Materials and methods
All chemicals were of the highest purity available and were obtained
from Bio-Rad (Munich, Germany), Boehringer-Mannheim (Mann-
heim, Germany), E. Merck (Darmstadt, Germany) and Molecular
Probes (Eugene, OR, USA). Lab-Trol protein standard is a product
of Merz and Dade (Munich, Germany).
2.1. Enzyme assays
Na/K-ATPase from pig kidney, with speci¢c enzyme activity of
25^27 U/mg protein, was isolated by a modi¢cation of JÖrgensen’s
procedure [16] and measured by a coupled spectrophotometric assay
[17]. One enzyme unit (U) is de¢ned as the amount of enzyme hydro-
lyzing 1 Wmol ATP per minute at 37‡C. Protein was determined by the
method of Lowry et al. [18] using Lab-Trol as protein standard. Lab-
Trol is a mixture of proteins and enzymes used for the calibration of
assays in clinical chemical analysis. All bu¡ers used were made up to
their respective pH value at room temperature.
K-activated p-nitrophenylphosphatase activity was measured on a
multititer plate by incubating the Na/K-ATPase at 37‡C in a total
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volume of 150 Wl containing 61 mM Tris-HCl (pH 7.25), 6.4 mM
MgCl2, 12 mM KCl and 5 mM p-nitrophenylphosphate. The reaction
was stopped after 15 min by the addition of 200 Wl 3 N NaOH. The
p-nitrophenolate formed was measured at 405 nm by an ELISA read-
er [3].
2.2. Inactivation of Na+/K+-ATPase with FITC and ErITC
Na/K-ATPase (6 U, 300 Wg) was incubated in a total volume of
1 ml overnight at 37‡C in a solution containing 20 mM Tris-HCl pH
7.25, 15 mM NaCl and 10 WM FITC. This inactivated enzyme was
centrifuged in Eppendorf tubes for 30 min at 100 000Ug. The pellet
was resuspended in 1 ml of a solution containing 20 mM Tris-HCl pH
7.25, 15 mM KCl and 2 WM ErITC. This preparation was incubated
additionally for 3 h at 37‡C, centrifuged and washed twice in 20 mM
Tris-HCl (pH 7.25). After the last centrifugation step, the protein was
resuspended in 0.3 ml of 20 mM Tris-HCl bu¡er of pH 7.25 (¢nal
concentration 1.8 mg/ml). The partial activities and speci¢city of the
labeled compounds were measured as described previously [2,3,11,19].
Notably, 5P-isothiocyanates like FITC or ErITC are reportedly potent
labels of both Cys and Lys residues at pH 7.25 [20].
2.3. Tryptic digestion
FITC-ErITC double-labeled Na/K-ATPase (166 mg) was sus-
pended in 8 M urea bu¡ered with (NH4)2HPO4 to pH 8. The ¢nal
protein concentration was 4 mg/ml. This solution was heated for 2 h
to 50‡C to solubilize the membrane bound enzyme. After dilution
with water in a ratio of 1:4 (¢nal urea concentration 2 M, protein
concentration 1 mg/ml) trypsin (sequencing grade) was added in a
ratio of 1:100 related to the protein concentration. After 24 h stand-
ing at room temperature, the same amount of trypsin was added a
second time. After additional 48 h of reaction, the membrane frag-
ments and the undigested protein was centrifuged for 30 min at
100 000Ug. The supernatant was concentrated by evaporation in a
Speed-Vac centrifuge. The ErITC-labeled peptides were puri¢ed by
rp-HPLC.
A reversed phase column Merck 250-3 Lichrospher WP300 PR-18
(5 Wm) was used to purify the ErITC-labeled tryptic fragments. The
peptides were eluted at 25‡C and a £ow rate of 300 Wl/min applying a
non-linear gradient of 2^90% B in A (bu¡er A: 25 mM KH2PO4-pH
7.0; bu¡er B: CH3CN). Unlabeled peptides were recorded at 210 nm,
peptides labeled with erythrosin were detected at 530 nm. The fraction
with the highest absorbance at 530 nm was collected and rechromato-
graphed isocratically on the same column in 50% water and 50%
CH3CN to clean the ErITC-labeled tryptic peptide.
2.4. Amino acid sequencing
The dried labeled peptide sample was dissolved in 90 Wl of 0.1%
tri£uoroacetic acid, 10% CH3CN, and 15 Wl of this solution was
applied to the Protein Support (Beckman). The sample was inserted
into the cartridge of the Protein Sequencer LF3600 (Beckman) and
analyzed by Edman degradation [21].
3. Results and discussion
In agreement with previous results [3], treatment of the pig
kidney enzyme with 10 WM FITC at pH 7.25 resulted in a
decrease of the ATP hydrolyzing activity of Na/K-ATPase
and left the E2ATP-site-speci¢c activity of K-dependent hy-
drolysis of p-nitrophenylphosphate almost unaltered (Table
1). This labeling resulted in 0.6 mol speci¢cally bound FITC
per mol K subunit; non-speci¢c labeling was detected and
corrected by the use of anti-£uorescein antibodies as described
previously [22]. In agreement with a previous report [11], ad-
dition of 2 WM ErITC modi¢ed the E2ATP site and inacti-
vated the remaining K-activated p-nitrophenylphosphatase
with a binding ratio of 0.5 mol erythrosin bound per mol K
subunit (Table 1).
Tryptic hydrolysis of the labeled enzyme and peptide puri-
¢cation by the rp-HPLC procedure (Fig. 1) yielded an eryth-
rosin-labeled peptide. Amino acid sequencing of the ErITC-
labeled peptides obtained by two independent isolations re-
sulted in the same sequence, viz. Val-Leu-Gly-Phe-Xxa-His.
Xxa stands for ErITC-modi¢ed amino acid residue, most
probably Cys549 which is due to its low yield in the Edman
degradation hard to detect and after derivatization virtually
undetectable. Comparison of this sequence with the K1 sub-
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Table 1
E¡ect of FITC and ErITC on the activities of Na/K-ATPase
Na/K-ATPase preparation Na/K-ATPase activity (%) p-Nitrophenylphosphatase (%) Mol label per mol K subunit
Native 100 100 ^
+10 WM FITC 91 V80 0.6
+2 WM ErITC 91 91 0.5
Native enzyme (6 U) was incubated in a total volume of 1 ml with 10 WM FITC and additionally with 2 WM ErITC. Inactivation of Na/K-
ATPase activity and p-nitrophenylphosphatase was measured as described in Section 2. Determination of the binding ratio was done according to
Linnertz et al. [11].
Fig. 1. Separation of tryptic peptides by rp-HPLC on a Merck 250-
3 Lichrospher WP300 RP-18 (5 Wm) column. Absorbance of the elu-
ate was recorded at 210 nm to detect all peptides and at 530 nm to
detect erythrosin-labeled peptides. The upper chromatogram shows
the peptide separation with a gradient of 2^90% acetonitrile in 25
mM KH2PO4 at pH 7.0. The lower chromatogram shows the re-
chromatography of the fraction with a retention time of 70^73 min
(the bar in the upper graph) in the ¢rst step under isocratic condi-
tions in a mixture of equal volumes of acetonitrile and 25 mM
KH2PO4 pH 7.0. The peak at 13.0^13.3 min (the bar in the lower
graph) was used for amino acid sequence analysis.
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unit of pig kidney Na/K-ATPase [23] showed identity with
the sequence Val545-Leu-Gly-Phe-Cys549-His550. The reason
why the peptide was digested between His550 and Leu551 by
sequence-grade trypsin is not clear. One may speculate that
the ErITC label residing at Cys549 is involved. SDS gel electro-
phoresis did not show peptides larger than 5 kDa (data not
shown).
As follows from the amino acid analysis of the ErITC-la-
beled peptide, Cys549 is the only possible amino acid residue in
this peptide that can form a covalent link with ErITC. It was
shown previously that cysteine can be modi¢ed by ErITC at
pH 7.25 [20], i.e. under conditions used in this work. Interest-
ingly, Cys549 (and the peptide starting from Val545) was sug-
gested as a part of the ATP binding site [24,25] in labeling
experiments with dihydro-4,4P-diisothiocyanatostilbene-2,2P-
disulfonate (H2-DIDS) which was used to modify the E1ATP
binding site of Na/K-ATPase. This compound labels one or
two amino acids of the enzyme in dependence on pH and was
also able to block its p-nitrophenylphosphatase activity. Sim-
ilar results were obtained with ErITC in this work (Table 1).
ErITC binds speci¢cally to the E2ATP site only at pH 7.25
(and shows no e¡ect at pH 9) in a E1ATP site-blocked (FITC-
labeled) enzyme [11]. The present ¢nding of Cys549 as an ami-
no acid of the speci¢c E2ATP label and the previous reports
with H2-DIDS [24,25] show that this region of the large cy-
tosolic H4/H5 loop is involved in the E2ATP binding site.
In conclusion, the low-a⁄nity E2ATP binding site has a
di¡erent speci¢city for ATP analogs [2,10] and it has a
more open structure [19]. Obviously, the conformation of
the ATP binding site di¡ers in both main conformations (E1
and E2) and Cys549 participates in the conformation of the
low-a⁄nity E2ATP binding site. It will be interesting to see
how a mutation of this residue a¡ects ATP binding and cat-
alysis.
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